Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ABEO — Abeona Therapeutics Inc.

CIK 886982 NEW YORK, NY
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,569,300
+$2,504,127 QoQ
Shares Held
1,224,806
+8.3% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 125 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ABEO ranks #171 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ABEO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,569,300 1,224,806
2026-03-31 $5,065,173 1,130,619
2025-12-31 $2,646,509 502,184
2025-09-30 $1,702,435 322,431
2025-06-30 $778,989 137,146
2025-03-31 $954,142 200,450
2024-12-31 $746,535 134,028
2024-03-31 $1,243,614 171,533
2023-06-30 $859,526 213,282
2023-03-31 $460,432 163,274
2022-12-31 $522,555 169,661
2021-09-30 $126,771 113,189
2021-06-30 $514,079 329,538
2021-03-31 $252,594 134,359
2020-12-31 $77,009 49,051
2020-09-30 $239,058 234,372
2020-06-30 $653,489 223,798
2020-03-31 $649,303 309,192